Cigna Corporation
General ticker "CI" information:
- Sector: Health Care
- Industry: Medical - Healthcare Plans
- Capitalization: $75.9B (TTM average)
Cigna Corporation follows the US Stock Market performance with the rate: 6.9%.
Estimated limits based on current volatility of 1.0%: low 277.89$, high 283.59$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-06-04, amount 1.56$ (Y2.21%)
- Total employees count: 73500 (+1.4%) as of 2024
- US accounted for 98.1% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Healthcare cost prediction, Market competition, Regulatory and compliance, Cybersecurity threats, IT system failures
- Price in estimated range
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [238.30$, 355.70$]
- 2026-12-31 to 2027-12-31 estimated range: [262.54$, 384.99$]
Financial Metrics affecting the CI estimates:
- Negative: with PPE of 9.2 at the end of fiscal year the price was high
- Positive: Operating cash flow per share per price, % of 13.10 > 13.08
- Positive: -4.23 < Operating profit margin, % of 3.35
- Positive: -9.15 < Industry operating profit margin (median), % of 1.57
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 3.83
- Negative: Investing cash flow per share per price, % of -6.02 <= -4.49
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Inventory ratio change, % of -0.04 <= 0
- Negative: Industry operating cash flow per share per price (median), % of 3.62 <= 5.56
Short-term CI quotes
Relationship graph
Long-term CI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $195,265.00MM | $247,121.00MM | $274,900.00MM |
| Operating Expenses | $186,729.00MM | $237,704.00MM | $265,700.00MM |
| Operating Income | $8,536.00MM | $9,417.00MM | $9,200.00MM |
| Non-Operating Income | $-3,023.00MM | $-4,148.00MM | $-1,419.00MM |
| Income(Loss) | $5,513.00MM | $5,269.00MM | $7,781.00MM |
| Taxes | $141.00MM | $1,491.00MM | $1,493.00MM |
| Net Income(Loss)* | $5,164.00MM | $3,434.00MM | $5,957.00MM |
| Stockholders Equity | $46,223.00MM | $41,033.00MM | $41,713.00MM |
| Inventory | $5,645.00MM | $6,692.00MM | $7,338.00MM |
| Assets | $152,761.00MM | $155,881.00MM | $157,919.00MM |
| Operating Cash Flow | $11,813.00MM | $10,363.00MM | $9,601.00MM |
| Capital expenditure | $1,573.00MM | $1,406.00MM | $1,212.00MM |
| Investing Cash Flow | $-5,174.00MM | $-2,102.00MM | $-4,407.00MM |
| Financing Cash Flow | $-4,294.00MM | $-7,647.00MM | $-6,421.00MM |
| Earnings Per Share** | $17.39 | $12.25 | $22.40 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.